Full Text View
Tabular View
Study Results
Related Studies
A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
This study has been completed.
Study NCT00812006   Information provided by Merck

First Received on December 17, 2008.   Last Updated on January 26, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Migraine
Additional conditions recognized in this trial
Migraine Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
Interventions listed in this trial
rizatriptan benzoate
Comparator: placebo
Additional drug interventions recognized in this trial
Benzoates
Rizatriptan
Topiramate
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Obesity Agents
Anticonvulsants
Antifungal Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Serotonin Agents
Serotonin Receptor Agonists
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services